Elsevier

Experimental Cell Research

Volume 197, Issue 2, December 1991, Pages 148-152
Experimental Cell Research

Regular article
Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation

https://doi.org/10.1016/0014-4827(91)90416-RGet rights and content

Abstract

4-Hydroxynonenal (HNE) is the major diffusible toxic product generated by lipid peroxidation of cellular membranes. The level of lipid peroxidation and, consequently, the concentration of its products are inversely related to the rate of cell proliferation and directly related to the level of cell differentiation. In the present paper the effects of HNE on the proliferation and differentiation of the HL-60 human promyelocytic cell line have been investigated. Repeated treatment at 45-min intervals with HNE (1 μM) was performed to maintain the cells in the presence of the aldehyde for 712 or 9 h. The effect of HNE on cell proliferation and differentiation was compared with dimethyl sulfoxide (DMSO)-treated cells. HNE causes a strong inhibition of cell growth without affecting cell viability. Moreover, HL-60 cells acquire the capability to produce chemiluminescence after soluble (phorbol myristate acetate) or corpuscolate (zymosan) stimulation. The phagocytic ability has also been calculated by counting the number of cells that phagocytize opsonized zymosan. Values were 43 and 55% after 10 or 12 HNE treatments, respectively, and 88% in DMSO-treated cells. Myeloperoxidase activity, 5 days after treatment, decreased by 85% in either HNE- or DMSO-treated cells while acid phosphatase activity increased with respect to untreated cells. Results obtained indicate that HNE at concentrations close to those found in the normal tissues can induce inhibition of proliferation and induction of differentiation in the HL-60 cell line.

References (34)

  • L. Paradisi et al.

    Chem. Biol. Interact

    (1985)
  • M.A. Rossi et al.

    Biochem. Pharmacol

    (1990)
  • F. Vincent et al.

    Exp. Cell Res

    (1991)
  • T. Okazaki et al.

    J. Biol. Chem

    (1990)
  • M. Saito et al.

    FEBS Lett

    (1990)
  • M. Hozumi

    Adv. Cancer Res

    (1983)
  • A. Yen

    Exp. Cell. Res

    (1985)
  • M. Baggiolini
  • A. Yen et al.

    Leuk. Res

    (1987)
  • C. Chomienne et al.

    Leuk. Res

    (1986)
  • J. Fontana et al.

    Exp. Cell. Res

    (1987)
  • L.E. Grosso et al.

    Biochem. Biophys. Res. Commun

    (1984)
  • R.U. Simpson et al.

    J. Biol. Chem

    (1987)
  • Y. Yufu et al.

    FEBS Lett

    (1990)
  • B. Halliwell et al.

    Free Radicals in Biology and Medicine

    (1985)
  • H. Esterbauer
  • H. Esterbauer et al.

    ISI Atlas Sci

    (1988)
  • Cited by (97)

    • Cancer growth regulation by 4-hydroxynonenal

      2017, Free Radical Biology and Medicine
      Citation Excerpt :

      Awasthi et al. showed that HNE differentially affect K562 cells overexpressing mGSTA4 cells, thus making them less susceptible to HNE-induced differentiation and apoptosis [24]. One of the first discoveries in studies on regulatory biological effects of HNE was observation that HNE can induce differentiation of K562 and of HL-60 leukemic cells [25,26]. Differentiation of HL-60 cells by HNE is initiated by an huge increase in peroxisome proliferation activating receptor γ (PPARγ), but not of PPARα expression, indicating targeted effects of HNE on PPARγ ligands [27].

    • Signaling by 4-hydroxy-2-nonenal: Exposure protocols, target selectivity and degradation

      2017, Archives of Biochemistry and Biophysics
      Citation Excerpt :

      To mimic a stable HNE level for longer exposure time as is observed in vivo, many studies treat cells with a repeated additions of HNE [50–55]. Such an exposure mode was first used by Barrera et al. to investigate HNE effects on cell differentiation [56]. This group systematically measured and compared HNE concentration in cell medium after bolus or repeated addition of HNE [57].

    • The inclusion complex of 4-hydroxynonenal with a polymeric derivative of β-cyclodextrin enhances the antitumoral efficacy of the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model

      2013, Free Radical Biology and Medicine
      Citation Excerpt :

      A similar observation can be made for PC3 and A375 cells treated with 10 μM free HNE, in that faint bands of cleaved PARP can be observed at 24 h in both cell lines, paralleling a weak, but significant, increase in stained trypan blue cells at 72 h. Further, in HL-60 cells, we have demonstrated that 10 μM HNE/PACM-βCD induced not only apoptosis but also cellular differentiation, whereas a single treatment with 10 μM free HNE did not. We previously demonstrated that differentiation induction occurred when HL-60 cells were maintained for 7.5 h in the presence of 1 μM HNE through the protocol of repeated treatments [34]. Thus, it appears that the induction of cell differentiation, which was higher with 10 μM HNE/PACM-βCD than with 10 μM free HNE treatment, can be related to the increased permanence of the aldehyde in the cell culture.

    • Oxidative Stress in Cultured Animal Cells

      2012, Animal Cell Biotechnology
    • Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells

      2011, Free Radical Biology and Medicine
      Citation Excerpt :

      These first observations indicated that HNE may control, even with different effectiveness, prostate cancer growth. Although these effects have been evidenced at supraphysiological concentrations of HNE, it has been demonstrated, in PC3 cancer cells and in other models of tumors, that HNE can exert analogous effects even if added at physiologically achievable concentrations for prolonged times [26–28]. On the other hand, HNE is normally found in human plasma at concentration of 0.65 μM in healthy subjects [29] and has been found in normal prostate as well as in precancerous and cancerous lesions [30,31].

    View all citing articles on Scopus

    This work was supported by the Association for International Cancer Research (U.K.) and by Consiglio Nazionale delle Ricerche (Special Project Oncology) Roma, Italy.

    View full text